Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Max Robinson.

Newcastle AuthorsTitleYearFull text
Dr Max Robinson
A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma2022
Daniel Lin
Dr Max Robinson
Professor Vinidh Paleri
Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with human papillomavirus-related squamous cell cancer: Long-term results2022
Dr Hans Sathasivam
Professor Philip Sloan
Professor Peter Thomson
Dr Max Robinson
The clinical utility of contemporary oral epithelial dysplasia grading systems2022
Dr Max Robinson
Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer2021
Dr Hans Sathasivam
Dr Ralf Kist
Professor Philip Sloan
Professor Peter Thomson
Michael Nugent
et al.
Predicting the clinical outcome of oral potentially malignant disorders using transcriptomic-based molecular pathology2021
Richard Walton
Dr Max Robinson
Professor Marco Carrozzo
A service evaluation of the diagnostic testing for mucous membrane pemphigoid in a UK Oral Medicine Unit2020
Dr Hans Sathasivam
John Casement
Professor Philip Sloan
Dr Max Robinson
Dr Ralf Kist
et al.
Gene expression changes associated with malignant transformation of oral potentially malignant disorders2020
Dr Hans Sathasivam
Professor Philip Sloan
Dr Ralf Kist
Dr Max Robinson
Prognostic Classifier for Oral Potentially Malignant Disorders: An Integrated Histopathological and Molecular approach2019
Dr Max Robinson
Nick West
Quality assurance guidance for scoring and reporting for pathologists and laboratories undertaking clinical trial work2019
Dr Max Robinson
Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach2019
Dr Max Robinson
Professor Philip Sloan
The use of digital pathology and image analysis in clinical trials2019
Dr Max Robinson
Professor Philip Sloan
Dr Andrew Hall
Training and accreditation standards for pathologists undertaking clinical trial work2019
Dr Hans Sathasivam
Benjamin Cosway
Professor Vinidh Paleri
Matt Kennedy
Dr Rachel Pearson
et al.
Clinicopathological features of squamous cell carcinoma of the oral cavity and oropharynx in young patients2018
Dr Hans Sathasivam
Paula Bradley
Professor Vinidh Paleri
Professor Philip Sloan
Dr Max Robinson
et al.
Concurrent HPV-related oropharyngeal carcinoma in four couples2018
Dr Max Robinson
Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams)2018
Dr Timothy Bates
Professor Jeffrey Pearson
Dr Max Robinson
Jason Powell
Laryngeal candidiasis: our experience from sixty biopsy specimens2018
Dr Max Robinson
Predictors of oropharyngeal cancer survival in Europe2018
Dr Max Robinson
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial2018
Dr Hans Sathasivam
James O'Hara
Dr David Meikle
Dr Charles Kelly
Dr Max Robinson
et al.
Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with high risk human papillomavirus related squamous cell cancer2018
Professor Vinidh Paleri
Dr David Meikle
James O'Hara
Dr Max Robinson
Transoral robotic surgery for residual and recurrent oropharyngeal cancers: Exploratory study of surgical innovation using the IDEAL framework for early-phase surgical studies2018
Dr Max Robinson
HPV testing of head and neck cancer in clinical practice2017
Dr Max Robinson
PET-NECK: A multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer2017
Dr Timothy Bates
Dr Michaela Goodson
Professor Peter Thomson
Professor Philip Sloan
Dr Ralf Kist
et al.
Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral Carcinogenesis2016
Professor Peter Thomson
Dr Max Robinson
Combined effects of smoking and HPV16 in oropharyngeal cancer2016
Dr Max Robinson
Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer2016
Dr Max Robinson
Professor Vinidh Paleri
Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials.2016
Dr Max Robinson
HOPX functions as a tumour suppressor in head and neck cancer2016
Dr Max Robinson
Professor Philip Sloan
HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology2016
Dr Max Robinson
Intraoperative sentinel lymph node evaluation: implications of cytokeratin 19 expression for the adoption of OSNA in oral squamous cell carcinoma2016
Dr Max Robinson
Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines2016
Dr Max Robinson
Professor Philip Sloan
Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines2016
Dr Max Robinson
Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx2016
Dr Max Robinson
PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer2016
Dr Max Robinson
PREDICTR Study: Biomarkers in Oro-Pharyngeal Squamous Cell Carcinoma2016
Michael Nugent
Dr Max Robinson
Should we test for high-risk human papilloma virus in patients with oral dysplasia?2016
Dr Max Robinson
Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach2016
Dr Max Robinson
Human papillomavirus testing in diagnostic head and neck pathology2015
Dr Max Robinson
IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer2015
Robert Banks
Dr Max Robinson
Juvenile xanthogranuloma: unusual intraoral finding2015
Professor Vinidh Paleri
Dr Max Robinson
Multicentric human papillomavirus-associated head and neck squamous cell carcinoma2015
Dr Michaela Goodson
Professor Philip Sloan
Dr Max Robinson
Professor Peter Thomson
Oral precursor lesions and malignant transformation - who, where, what, and when?2015
Dr Joanne Patterson
Dr Max Robinson
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer2015
Dr Max Robinson
PET-NECK: A multi-centre, randomized, phase III, controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNSCC) treated with primary radical chemoradiotherapy (CRT)2015
Anne Chambers
Dr Max Robinson
Robert Banks
Professor Philip Sloan
Twenty-first-century oral hairy leukoplakia-a non-HIV-associated entity2015
Dr Max Robinson
Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma: Best Practice for Diagnosis2014
Professor Vinidh Paleri
Dr Max Robinson
Patients with HPV-related tonsil squamous cell carcinoma rarely harbour oncogenic HPV infection at other pharyngeal sites2014
Dr Timothy Bates
Professor Peter Thomson
Professor Philip Sloan
Dr Max Robinson
Dr Ralf Kist
et al.
PAX9 expression in potentially malignant disorders and early stage squamous carcinoma of the oral cavity2014
Dr Timothy Bates
Dr Max Robinson
Small Cell Neuroendocrine Carcinoma of the Oropharynx Harbouring Oncogenic HPV-Infection2014
Professor Philip Sloan
Dr Max Robinson
Squamous Cell Carcinoma of the Head and Neck Outside the Oropharynx Is Rarely Human Papillomavirus Related2014
Dr Ralf Kist
Michelle Watson
Moira Crosier
Dr Max Robinson
Dr Julia Reichelt
et al.
The Formation of Endoderm-Derived Taste Sensory Organs Requires a Pax9-Dependent Expansion of Embryonic Taste Bud Progenitor Cells2014
Dr Ameena Diajil
Dr Max Robinson
Professor Philip Sloan
Professor Peter Thomson
Clinical Outcome Following Oral Potentially Malignant Disorder Treatment: A 100 Patient Cohort Study2013
Dr Max Robinson
Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population2013
Dr Max Robinson
Professor Vinidh Paleri
Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population2013
Dr Max Robinson
Professor Vinidh Paleri
Salivary gland swellings2013
Dr Michael Drinnan
Dr Max Robinson
Dr David Meikle
Andrew Welch
Dr Ivan Zammit-Maempel
et al.
Thyroid gland invasion in total laryngectomy and total laryngopharyngectomy: a systematic review and meta-analysis of the English literature2013
Professor Philip Sloan
Dr Max Robinson
Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma2013
Dr Max Robinson
Detection of Oncogenic Human Papillomavirus in Nasopharyngeal Carcinoma2012
Dr Timothy Bates
Dr Tuomo Polvikoski
Professor Philip Sloan
Dr David Meikle
Dr Max Robinson
et al.
Ganglioneuroblastic transformation in olfactory neuroblastoma2012
Dr Max Robinson
Professor Philip Sloan
HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients2012
Dr Max Robinson
Professor Vinidh Paleri
Salivary gland swellings2012
Dr Max Robinson
The Pathology of Virus-Related Carcinomas of the Upper Aerodigestive Tract2012
Professor Philip Sloan
Dr Max Robinson
Validation for a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma.2012
Dr Max Robinson
Professor Philip Sloan
Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity and prognostic discrimination2011
Professor Philip Sloan
Dr Max Robinson
Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice2011
Dr Christine Challen
Professor Philip Sloan
Professor Mark Birch-Machin
Dr Max Robinson
Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility2011
Dr Max Robinson
Squamous cell carcinoma of the oral cavity rarely harbours oncogenic human papillomavirus2011
Robert Shaw
Dr Max Robinson
The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer2011
Dr Max Robinson
Professor Philip Sloan
CD56 (NCAM) expression in ameloblastomas and other odontogenic lesions2010
Dr Max Robinson
Professor Philip Sloan
Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing2010
Dr Max Robinson
Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation2009
Professor Vinidh Paleri
Dr Max Robinson
Polymorphous low-grade adenocarcinoma of the head and neck2008
Dr Max Robinson
Expression of Ki-67 and p53 in cutaneous free flaps used to reconstruct soft tissue defects following resection of oral squamous cell carcinoma2007
Dr Max Robinson
Spindle assembly checkpoint and centrosome abnormalities in oral cancer2007
Dr Max Robinson
An investigation into the practice of tongue piercing in the South West of England2006
Dr Max Robinson
Lichenoid and granulomatous stomatitis: an entity or a non-specific inflammatory process?2006
Dr Max Robinson
Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways2005
Dr Max Robinson
Attenuated type II TGF-β receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic dissemination2004
Dr Max Robinson
Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-β12004
Dr Max Robinson
A study of the clinical characteristics of benign trigeminal sensory neuropathy2003
Dr Max Robinson
Functional significance of MMP-2 and MMP-9 expression by human malignant oral keratinocyte cell lines2003
Dr Max Robinson
TGF-β1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G1 arrest2002
Dr Max Robinson
Decreased expression of TGF-β cell surface receptors during progression of human oral squamous cell carcinoma2001
Dr Max Robinson
Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation2001
Dr Max Robinson
Oral Psoriasis1996